TABLE 2.
Distribution of Mycobacterium tuberculosis strains isolated from PTB patients, Tigray Region Ethiopia, July 2018–August 2019.
Study site (hospitals) | N (%) | DR profile | L1, F (%) | L2, F (%) | L3, F (%) | L4, F (%) | Total, F (%) |
Alamata | 4 (5.9) | Pre-XDR | − | − | − | − | − |
MDR | − | − | − | 2 (50) | 2 (50) | ||
DR | 1 (25) | 1 (25) | |||||
Pan susceptible | − | − | 1 (25) | − | 1 (25) | ||
Mekelle | 34 (50) | Pre-XDR | − | − | 1 (2.9) | − | 1 (2.9) |
MDR | − | − | 3 (8.8) | 11 (32.4) | 14 (41.2) | ||
DR | 1 (2.9) | − | 1 (2.9) | ||||
Pan susceptible | − | − | 8 (23.5) | 10 (29.4) | 1 (52.9) | ||
Adigrat | 18 (26.5) | Pre-XDR | − | − | − | − | − |
MDR | − | − | 1 (5.6) | 1 (5.6) | 2 (11.1) | ||
DR | 1 (5.6) | 1 (5.6) | 2 (11.1) | ||||
Pan susceptible | 1 (5.6) | − | 8 (44.4) | 5 (27.8) | 14 (77.8) | ||
Adwa | 3 (4.4) | Pre-XDR | − | − | − | − | − |
MDR | − | − | − | 1 (33.3) | 1 (33.3) | ||
DR | 2 (66.7) | 2 (66.7) | |||||
Pan susceptible | − | − | − | − | − | ||
Shire | 7 (10.3) | Pre-XDR | − | − | − | − | − |
MDR | − | − | 1 (14.3) | 1 (14.3) | 2 (28.6) | ||
DR | 1 (14.3) | 1 (14.3) | |||||
Pan susceptible | − | − | 3 (42.9) | 1 (14.3) | 4 (57.1) | ||
Humera | 2 (2.9) | Pre-XDR | − | − | − | − | − |
MDR | − | − | 1 (50) | 1 (50) | 2 (100) | ||
DR | − | − | − | − | − | ||
Pan susceptible | − | − | − | − | − | ||
Total | 68 (100) | 1 (1.5) | 1 (1.5) | 28 (41.2) | 38 (55.8) | 68 (100) |
N, number; F, frequency; DR, drug resistance; MDR, multi drug resistant; Pre-XDR, Pre-extensively drug resistant.